{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:37Z","timestamp":1786123357247,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Acute respiratory distress syndrome (ARDS) is a result of diffuse lung injury and dysregulated inflammation. Recent studies have demonstrated that B cells can perform anti-inflammatory and tissue-protective functions. We hypothesized that systemic B-cell administration could have therapeutic effects in hyperoxic acute lung injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Acute lung injury was modeled in adult C57BL\/6J male mice through continuous exposure to hyperoxia (FiO\n                      <jats:sub>2<\/jats:sub>\n                      &gt;90%). Mature B cells (CD45R\n                      <jats:sup>+<\/jats:sup>\n                      \/CD19\n                      <jats:sup>+<\/jats:sup>\n                      ) were purified from spleens of age- and sex-matched C57BL\/6J mice. B cells (10\n                      <jats:sup>7<\/jats:sup>\n                      ) or saline were administered intravenously after 24 hours of hyperoxia. Hyperoxia exposure was continued for up to 96 hours. The effects of adoptive B-cell therapy were assessed using histologic, physiologic (pulse oximetry, echocardiography), and immunologic (flow cytometry) readouts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Hyperoxia led to a 50% depletion of endogenous pulmonary B cells by day 3, from 30% to 15% CD45\n                      <jats:sup>+<\/jats:sup>\n                      lung immune cells (95% confidence interval [CI], 6.16\u201324.45;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0017). B-cell administration ameliorated B-cell loss, improved lung injury scores (median score in saline-treated = 3.0 vs B-cell-treated = 2.67;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0101) and lung cellular infiltration (F [2,34] = 11.99;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0001). By day 3, B cells limited the duration of oxygen desaturations (difference 0.39 seconds; median length = 1.01 seconds in saline-treated vs 0.62 seconds in B-cell-treated; 95% CI, 0.02\u20130.73 seconds;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .03) and their depth (median nadir = 82.0% in saline-treated vs 85.9% in B-cell-treated, 95% CI, \u22126.6% to \u22120.84%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .04). B-cell-treated mice showed a median 3.82% increase in left ventricular ejection fraction by day 3, compared to 12.35% in saline-treated mice (mean difference 7.32%; 95% CI, \u22125.0% to 19.6%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .23). Exogenous B cells represented less than 1.5% of pulmonary B cells on day 3. B-cell administration had homeostatic effects on relative abundance of pulmonary immune subsets affected by hyperoxia, including endogenous B cells, CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells, natural killer (NK) cells, monocytes\/macrophages, and neutrophils. Significant immunomodulatory effects of B-cell administration were observed in myeloid cells in the lungs and included reductions in the proportion of interleukin-17 (IL-17)-expressing Ly6C\n                      <jats:sup>lo<\/jats:sup>\n                      monocytes (F [2,14] = 19.02;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0001), alveolar macrophages (F [2,14] = 10.32;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0018), and neutrophils (F [2,14] = 6.621;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0095) as well as interferon-gamma (IFN\u03b3)-expressing Ly6C\n                      <jats:sup>lo<\/jats:sup>\n                      monocytes (F [2,14] = 48.83;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Our data indicate that adoptive B-cell therapy ameliorates hyperoxic lung injury and may represent a novel treatment for ARDS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000007545","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T13:00:30Z","timestamp":1750683630000},"page":"403-415","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Protective and Immunomodulatory Functions of Exogenous B Cells in Experimental Hyperoxic Lung Injury"],"prefix":"10.1213","volume":"142","author":[{"given":"Dusan","family":"Hanidziar","sequence":"first","affiliation":[{"name":"From theDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam J.","family":"Dwyer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia L.","family":"Ranjeva","sequence":"additional","affiliation":[{"name":"From theDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Csizmadia","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Center for Inflammation Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Maheshwari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D.","family":"Valencia","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Center for Inflammation Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Aspden","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Farhat","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Center for Inflammation Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo E.","family":"Otterbein","sequence":"additional","affiliation":[{"name":"Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Robson","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Center for Inflammation Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra F.","family":"S\u00eerbulescu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, Massachusetts"},{"name":"Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Poznansky","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201703-0548ST","article-title":"An Official American Thoracic Society\/European Society of Intensive Care Medicine\/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome.","volume":"195","author":"Fan","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13054-020-2826-6","article-title":"Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study.","volume":"24","author":"Madotto","year":"2020","journal-title":"Crit Care"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4187\/respcare.01963","article-title":"Hyperoxic acute lung injury.","volume":"58","author":"Kallet","year":"2013","journal-title":"Respir Care"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"L12","DOI":"10.1152\/ajplung.00304.2020","article-title":"Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19.","volume":"320","author":"Hanidziar","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.4049\/jimmunol.172.6.3860","article-title":"CXCR2 is critical to hyperoxia-induced lung injury.","volume":"172","author":"Sue","year":"2004","journal-title":"J Immunol"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"606678","DOI":"10.3389\/fmed.2021.606678","article-title":"Hyperoxia and lungs: what we have learned from animal models.","volume":"8","author":"Amarelle","year":"2021","journal-title":"Front Med"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1152\/jappl.1991.71.6.2352","article-title":"Responses of baboons to prolonged hyperoxia: physiology and qualitative pathology.","volume":"71","author":"Fracica","year":"1991","journal-title":"J Appl Physiol"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"L379","DOI":"10.1152\/ajplung.00010.2008","article-title":"Animal models of acute lung injury.","volume":"295","author":"Matute-Bello","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R9-20260109","first-page":"273","article-title":"Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days. A morphometric and hemodynamic study.","volume":"117","author":"Jones","year":"1984","journal-title":"Am J Pathol"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1038\/s41598-020-61489-y","article-title":"Characterization of pulmonary immune responses to hyperoxia by high-dimensional mass cytometry analyses.","volume":"10","author":"Hanidziar","year":"2020","journal-title":"Sci Rep"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","article-title":"Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.","volume":"166","author":"Hotchkiss","year":"2001","journal-title":"J Immunol"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/CCM.0000000000002380","article-title":"Activation-Associated accelerated apoptosis of memory B cells in critically Ill patients with sepsis.","volume":"45","author":"Shankar-Hari","year":"2017","journal-title":"Crit Care Med"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.ymthe.2020.10.001","article-title":"COVID-19-Induced ARDS is associated with decreased frequency of activated memory\/Effector T cells expressing CD11a+.","volume":"28","author":"Anft","year":"2020","journal-title":"Mol Ther"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"1207960","DOI":"10.3389\/fcell.2023.1207960","article-title":"Documenting the immune response in patients with COVID-19-induced acute respiratory distress syndrome.","volume":"11","author":"Lu","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"611004","DOI":"10.3389\/fimmu.2020.611004","article-title":"B cell subsets as severity-associated signatures in COVID-19 patients.","volume":"11","author":"Sosa-Hern\u00e1ndez","year":"2020","journal-title":"Front Immunol"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1165\/rcmb.2016-0395OC","article-title":"Gene expression analysis to assess the relevance of rodent Models to Human Lung Injury.","volume":"57","author":"Sweeney","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"e20210409","DOI":"10.1084\/jem.20210409","article-title":"Marginating transitional B cells modulate neutrophils in the lung during inflammation and pneumonia.","volume":"218","author":"Podstawka","year":"2021","journal-title":"J Exp Med"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"e1003472","DOI":"10.1371\/journal.ppat.1003472","article-title":"B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response.","volume":"9","author":"Kozakiewicz","year":"2013","journal-title":"PLoS Pathog"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"e78291","DOI":"10.7554\/eLife.78291","article-title":"A neutrophil-B-cell axis impacts tissue damage control in a mouse model of intraabdominal bacterial infection via Cxcr4.","volume":"11","author":"Gawish","year":"2022","journal-title":"Elife"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"31226","DOI":"10.1074\/jbc.M301820200","article-title":"Pulmonary expression of leukemia inhibitory factor induces B cell hyperplasia and confers protection in hyperoxia.","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/wrr.12584","article-title":"Mature B cells accelerate wound healing after acute and chronic diabetic skin lesions.","volume":"25","author":"S\u00eerbulescu","year":"2017","journal-title":"Wound Repair Regen"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1089\/neu.2018.6368","article-title":"Intraparenchymal application of mature B Lymphocytes improves structural and functional outcome after contusion traumatic brain injury.","volume":"36","author":"S\u00eerbulescu","year":"2019","journal-title":"J Neurotrauma"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"e22019","DOI":"10.1096\/fj.202101095RR","article-title":"B cells support the repair of injured tissues by adopting MyD88-dependent regulatory functions and phenotype.","volume":"35","author":"S\u00eerbulescu","year":"2021","journal-title":"FASEB J"},{"key":"R24-20260109","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1165\/rcmb.2012-0180OC","article-title":"Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury.","volume":"48","author":"Nowak-Machen","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R25-20260109","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1101\/pdb.prot073411","article-title":"Manual hematoxylin and eosin staining of mouse tissue sections.","volume":"2014","author":"Cardiff","year":"2014","journal-title":"Cold Spring Harb Protoc"},{"key":"R26-20260109","doi-asserted-by":"crossref","first-page":"e13398","DOI":"10.14814\/phy2.13398","article-title":"Nfib hemizygous mice are protected from hyperoxic lung injury and death.","volume":"5","author":"Kumar","year":"2017","journal-title":"Physiol Rep"},{"key":"R27-20260109","doi-asserted-by":"crossref","first-page":"L1050","DOI":"10.1152\/ajplung.00067.2006","article-title":"Dissociation between alveolar transmigration of neutrophils and lung injury in hyperoxia.","volume":"291","author":"Perkowski","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R28-20260109","first-page":"3004","article-title":"Ultrastructural alteration of pulmonary tissue under conditions of high oxygen concentration.","volume":"13","author":"Yano","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"R29-20260109","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","article-title":"An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals.","volume":"44","author":"Matute-Bello","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R30-20260109","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1165\/rcmb.2021-0531ST","article-title":"Update on the features and measurements of experimental acute lung injury in animals: An Official American Thoracic Society Workshop Report.","volume":"66","author":"Kulkarni","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R31-20260109","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fphys.2017.00555","article-title":"Pattern analysis of oxygen saturation variability in healthy individuals: entropy of pulse oximetry signals carries information about mean oxygen saturation.","volume":"8","author":"Bhogal","year":"2017","journal-title":"Front Physiol"},{"key":"R32-20260109","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1113\/EP088755","article-title":"A network physiology approach to oxygen saturation variability during normobaric hypoxia.","volume":"106","author":"Jiang","year":"2021","journal-title":"Exp Physiol"},{"key":"R33-20260109","doi-asserted-by":"crossref","first-page":"e15546","DOI":"10.14814\/phy2.15546","article-title":"Reduced oxygen saturation entropy is associated with poor prognosis in critically ill patients with sepsis.","volume":"10","author":"Gheorghita","year":"2022","journal-title":"Physiol Rep"},{"key":"R34-20260109","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00251-006-0147-9","article-title":"Genetic basis of murine responses to hyperoxia-induced lung injury.","volume":"58","author":"Whitehead","year":"2006","journal-title":"Immunogenetics"},{"key":"R35-20260109","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1165\/rcmb.2011-0204OC","article-title":"Cardiac physiologic and genetic predictors of hyperoxia-induced acute lung injury in mice.","volume":"46","author":"Howden","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R36-20260109","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1152\/jappl.2001.90.6.2221","article-title":"Hyperoxia-induced changes in mouse lung mechanics: forced oscillations vs. barometric plethysmography.","volume":"90","author":"Pet\u00e1k","year":"2001","journal-title":"J Appl Physiol"},{"issue":"Pt 14","key":"R37-20260109","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1242\/jeb.200.14.2057","article-title":"Trafficking of adoptively transferred B lymphocytes in B-lymphocyte-deficient mice.","volume":"200","author":"Roth","year":"1997","journal-title":"J Exp Biol"},{"key":"R38-20260109","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1113\/expphysiol.2014.083337","article-title":"Exogenous interleukin-10 attenuates hyperoxia-induced acute lung injury in mice.","volume":"100","author":"Li","year":"2015","journal-title":"Exp Physiol"},{"key":"R39-20260109","doi-asserted-by":"crossref","first-page":"e12155","DOI":"10.14814\/phy2.12155","article-title":"Adenosine promotes vascular barrier function in hyperoxic lung injury.","volume":"2","author":"Davies","year":"2014","journal-title":"Physiol Rep"},{"key":"R40-20260109","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.taap.2013.06.007","article-title":"Sex-specific differences in hyperoxic lung injury in mice: implications for acute and chronic lung disease in humans.","volume":"272","author":"Lingappan","year":"2013","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:28:30Z","timestamp":1786112910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000007545","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}